Why it was recalled
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Product description
INTEGRA 325/40/3mg 90-count bottle, NDC: 52747-710-60
Lot numbers, UPCs & expiration codes
All Lots distributed 02/23/2021 through 03/10/2021.
Where it was sold
FL, GA, SC
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0588-2021
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Mar 15, 2021
- FDA report date
- Jun 2, 2021
- Quantity
- 32 bottles
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Cardinal Health Inc.
Original FDA data
Every field from FDA enforcement report D-0588-2021, exactly as published.
Show all FDA fields
- City
- Dublin
- State
- OH
- Status
- Terminated
- Country
- United States
- Event ID
- 87512
- Address
- 7000 Cardinal Pl
- Code information
- All Lots distributed 02/23/2021 through 03/10/2021.
- Postal code
- 43017-1091
- Report date
- Jun 2, 2021
- Product type
- Drugs
- Recall number
- D-0588-2021
- Classification
- Class II
- Recalling firm
- Cardinal Health Inc.
- Product quantity
- 32 bottles
- Termination date
- Jun 17, 2024
- Reason for recall
- CGMP Deviations: Intermittent exposure to temperature excursion during storage.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- INTEGRA 325/40/3mg 90-count bottle, NDC: 52747-710-60
- Distribution pattern
- FL, GA, SC
- Recall initiation date
- Mar 15, 2021
- Initial firm notification
- Letter
- Center classification date
- May 24, 2021